Purchase Order HHSP284201700196A
- Not listed
- This federal contract award is for the delivery of the IXIARO vaccine to the U.S. government. The contract, valued at $179,538.25, was awarded to Valneva USA, Inc., a subsidiary of the French specialty vaccine company Valneva SE. The contract is a firm fixed price Delivery Order placed against the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule Contract. This contract does not have a set-aside designation. Valneva USA, Inc. has been a key supplier of vaccines, particularly the...
- The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded a $148,200.00 firm fixed price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.) for the IXIARO vaccine. Valneva USA is a subsidiary of the French specialty vaccine company Valneva SE. The contract has no set-aside designation and was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The IXIARO vaccine is used to protect against...
- This federal contract award, valued at $10,638,400.00, was issued by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, for the supply of the Japanese encephalitis vaccine IXIARO. The contract is a firm fixed price delivery order with a period of performance through September 30, 2024. Valneva USA, a subsidiary of the France-based Valneva SE, is the prime contractor and holds several other significant...
- The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded a firm fixed price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a foreign-owned for-profit organization, to provide the IXIARO vaccine. The contract has a potential value of $112,564.50 and a completion date of March 22, 2024. This delivery order is part of Valneva USA's GSA Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). Valneva USA has...
- This is a federal contract award to Valneva USA, Inc., doing business as Intercell USA Inc., for the supply of the IXIARO Japanese encephalitis vaccine. The $86,608.50 fixed-price purchase order was awarded on February 25, 2016 by the Office of the Assistant Secretary for Administration, a civilian federal agency. The contract has a completion date of March 11, 2016 and was not set aside for any specific business type. Valneva USA is a foreign-owned, for-profit organization that specializes in...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.) to provide the IXIARO vaccine. The contract has a potential value of $279,075.00 and the period of performance runs through April 30, 2019. Valneva USA, a subsidiary of the specialty vaccine company Valneva SE, is the prime contractor and will fulfill the order from its facility in Potomac, Maryland. The contract was...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc., doing business as Intercell USA Inc. The contract is for the provision of the Japanese encephalitis vaccine IXIARO, with a potential value of $3,203,200.00 and a completion date of January 19, 2024. Valneva USA, a subsidiary of the specialty vaccine company Valneva SE, has received numerous prime federal contract awards, primarily from the Defense Logistics...
- This federal contract award, SPE2DP16D0003|0001, was issued by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc., doing business as Intercell USA Inc. The contract is for the delivery of the Japanese encephalitis vaccine IXIARO, and has a ceiling value of $9,262,750.00. The contract was awarded on March 18, 2016, with a completion date of July 18, 2016, and is a Firm Fixed Price Delivery Order. The award was not set aside for any particular business classification....
- The U.S. Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the specialty vaccine company Valneva SE. The $12,790,400.00 contract is for the delivery of the Japanese encephalitis vaccine IXIARO, with a completion date of March 13, 2024. This award is likely associated with Valneva USA's existing Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with the Defense...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a foreign-owned for-profit organization, to provide the IXIARO vaccine. The $111,630.00 contract is not associated with a set-aside program and is being fulfilled at Valneva's facility in Potomac, Maryland. Valneva USA has received multiple federal vaccine contracts, primarily for the Department of Defense, Department of...
This federal contract award is for the delivery of the IXIARO vaccine to the U.S. government. The contract, valued at $80,160.00, was awarded to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is a firm fixed-price purchase order with a completion date of June 16, 2017. Valneva USA, Inc. is the prime contractor for this award, which is not set aside. The company has been awarded multiple federal contracts and indefinite delivery vehicles (IDVs) by various agencies, including the Defense Logistics Agency, Department of Veterans Affairs, Department of Health and Human Services, and the Federal Bureau of Investigation. These contracts and IDVs, ranging from $18,000 to $198 million, enable Valneva USA to supply a variety of vaccines, including the Japanese encephalitis vaccine IXIARO, to support medical readiness, public health initiatives, and protection against infectious disease threats for military personnel, federal employees, and the general public.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $80.2k | 5/31/17 |